Gastrointestinal: Having to do with the digestive tract, which includes the mouth, esophagus, stomach, and intestines.
Gene therapy: The use of genes to treat cancer and other diseases.
Genetic mutation: A permanent change to the normal sequence of a gene, usually caused by external agents such as chemicals or radiation. Genetic mutations may cause certain cancers.
Hemophagocytic syndrome: A serious condition in which there is uncontrolled activation of certain parts of the immune system. It can occur in certain types of NHL: subcutaneous panniculitis-like T-cell lymphoma and extranodal T-cell lymphoma of nasal type.
Hepatosplenomegaly: Abnormal enlargement of both the liver and spleen.
Histiocytic lymphoma: The old Rappaport classification for the form of NHL now known as large cell lymphoma.
HTLV-1 infection: HTLV stands for human T-lymphotropic virus. It is a family of viruses that infects T-cells and can make people more likely to develop a certain type of NHL: adult T-cell lymphoma. This virus is rare in North America and is more common in countries such as Japan and China.
Hyperviscosity: Abnormal thickening of the blood.
Immune system: The system within the body that recognizes and fights foreign cells and disease.
Immunotherapy: Treatments that stimulate the patient’s immune system to fight infection or disease. Also called biologic therapy.
Improvement: Tthe term used when the tumour size has decreased but is still larger than half of its original size.
Induction therapy: Cancer treatment used as the first step towards shrinking the tumour(s). If necessary, induction therapy is followed by additional therapy to treat the remaining cancer cells/tumours.
top